Cargando…
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
microRNA-143 (miR-143) is a well-known tumor suppressive microRNA that exhibits anti-tumoral function by targeting KRAS signaling pathways in various malignancies. We hypothesized that miR-143 suppresses breast cancer progression by targeting KRAS and its effector molecules. We further hypothesized...
Autores principales: | Tokumaru, Yoshihisa, Asaoka, Mariko, Oshi, Masanori, Katsuta, Eriko, Yan, Li, Narayanan, Sumana, Sugito, Nobuhiko, Matsuhashi, Nobuhisa, Futamura, Manabu, Akao, Yukihiro, Yoshida, Kazuhiro, Takabe, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246786/ https://www.ncbi.nlm.nih.gov/pubmed/32370060 http://dx.doi.org/10.3390/ijms21093213 |
Ejemplares similares
-
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020) -
Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019) -
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020) -
Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2021) -
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer
por: Oshi, Masanori, et al.
Publicado: (2020)